Literature DB >> 2935360

Generation of C3d,g and C3d by urokinase-treated plasma in association with fibrinolysis.

T Seya, S Nagasawa, M Matsukura, H Hasegawa, J P Atkinson.   

Abstract

In the breakdown of fluid phase C3 in plasma, the process of conversion of iC3b to C3c and 'C3d' has not been elucidated. Using fluorescent labeled iC3b as a substrate, urokinase (UK) treated but not normal plasma was found to exhibit effective 'C3d' production. To address the relationship between the fibrinolytic activity specific for UK-activated plasma and this 'C3d' production, an assay system was developed that permitted the simultaneous determination of both activities. This method indicated that 'C3d' generation paralleled that of plasmin-dependent fibrinogen degradation. A Km of iC3b for plasmin was 3.0 X 10(-6) mol/l which is similar to the Km of fibrinogen. Plasmin cleavage of iC3b gave rise to C3d1 (Mr 42,000) and C3d2 (Mr 28,000). Purified plasmin C3d1 showed the same Mr and pI as C3d,g prepared from iC3b, by H and I. C3d2 was derived from C3d1. From these in vitro experiments with urokinase-treated plasma, we conclude that in parallel with fibrinolysis efficient cleavage of fluid phase iC3b to C3c + C3d,g and C3d occurs and we hypothesize that this is one mechanism for the generation of C3d in vivo.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2935360     DOI: 10.1159/000467857

Source DB:  PubMed          Journal:  Complement        ISSN: 0253-5076


  8 in total

1.  Plasminogen is a complement inhibitor.

Authors:  Diana Barthel; Susann Schindler; Peter F Zipfel
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

Review 2.  Evolution of the complement system: from defense of the single cell to guardian of the intravascular space.

Authors:  Michelle Elvington; M Kathryn Liszewski; John P Atkinson
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

3.  Functional properties of membrane cofactor protein of complement.

Authors:  T Seya; J P Atkinson
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

4.  Serum hypercoagulability states in Coats' disease.

Authors:  Fariba Ghassemi; Carol L Shields; Masoumeh Mohebbi; Mehdi Nili Ahmadabadi; Fatemeh Morsali; Siamak Sabour
Journal:  Clin Ophthalmol       Date:  2017-02-08

5.  A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3.

Authors:  K Hess; S H Alzahrani; M Mathai; V Schroeder; A M Carter; G Howell; T Koko; M W J Strachan; J F Price; K A Smith; P J Grant; R A Ajjan
Journal:  Diabetologia       Date:  2011-09-15       Impact factor: 10.122

6.  Staphylococcus aureus proteins Sbi and Efb recruit human plasmin to degrade complement C3 and C3b.

Authors:  Tina K Koch; Michael Reuter; Diana Barthel; Sascha Böhm; Jean van den Elsen; Peter Kraiczy; Peter F Zipfel; Christine Skerka
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

7.  Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.

Authors:  T Seya; J R Turner; J P Atkinson
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

8.  Minor Role of Plasminogen in Complement Activation on Cell Surfaces.

Authors:  Satu Hyvärinen; T Sakari Jokiranta
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.